DAVID J. PROPPER

5.4k citations
84 papers · 4.4k · 1 hit paper · h-index 31

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Cancer Cells and Metastasis
    • CAR-T cell therapy research

Papers in

    • Pancreatic and Hepatic Oncology Research 13
    • Colorectal Cancer Treatments and Studies 11
    • Renal Transplantation Outcomes and Treatments 12

DAVID J. PROPPER

83 papers receiving 4.3k citations

DAVID J. PROPPER's Hit Papers

Harnessing cytokines and chemokines for cancer therapy 2022 · 784 citations
7840+1+2Years since publication250500750

Peers

DAVID J. PROPPER
Comparison fields: 5 of 125
  • Internal Medicine 228
  • Oncology 1.6k
  • Cancer Research 364
  • Immunology 485
  • Hematology 210
Replace Gerald W. Prager with:
Gerald W. Prager Austria
Petr Kavan Canada
Benjamin Drewinko United States
Yang Lü United States
Kiyohiko Hatake Japan
Jermaine I Coward Australia
Aiwu Ruth He United States
Stefan Hubert Boeck Germany
Toshiharu Kamura Japan
Marcus Bahra Germany
DAVID J. PROPPER relative to Gerald W. Prager Austria Gerald W. Prager's profile →
Citations per field
00.5×2×3.3×
Gerald W. Prager · 1×
Citations per year

Countries citing papers authored by DAVID J. PROPPER

Since Specialization
Citations

This map shows the geographic impact of DAVID J. PROPPER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DAVID J. PROPPER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DAVID J. PROPPER more than expected).

Fields of papers citing papers by DAVID J. PROPPER

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DAVID J. PROPPER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DAVID J. PROPPER. The network helps show where DAVID J. PROPPER may publish in the future.

Co-authors

The 25 scholars most cited alongside DAVID J. PROPPER, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with DAVID J. PROPPER Line = papers co-authored together DAVID J. PROPPER links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Harnessing cytokines and chemokines for cancer therapy
Hit paper breakdown →
2022784
2 2014327
3 2011261
4 2011211
5 2013207
6 2001203
7 2020184
8 2008156
9 2018142
10 2018133
11 2018129
12
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
2001116
13 1999114
14 2018106
15
Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma.
200393
16 200475
17 201765
18
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
200057
19 199955
20 200354

About DAVID J. PROPPER

DAVID J. PROPPER is a scholar working on Oncology, Transplantation, Immunology, Hematology and Cancer Research, having authored 84 papers that have together received 4.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Renal Transplantation Outcomes and Treatments (12 papers), Colorectal Cancer Treatments and Studies (11 papers), T-cell and B-cell Immunology (9 papers), Blood groups and transfusion (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Immunotoxicology and immune responses (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Internal Medicine (228 citations), Oncology (1.6k citations), Cancer Research (364 citations), Immunology (485 citations) and Hematology (210 citations). DAVID J. PROPPER has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Frances R. Balkwill, Adrian L. Harris, Trivadi Sundaram Ganesan, Jeremy P. Braybrooke, Kenneth John O'Byrne, Denis Charles Talbot, Roger M. Feakins, Nicola A. Dobbs, Kevin R. Wedgwood and Anthony Maraveyas. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, The Lancet Oncology, Transplantation and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact